Sectors

Kidney disease-focused drug developer Walden was co-founded by faculty members of Rush University and Harvard University earlier this year.

Baidu-backed surgical telemedicine system developer Avail Medsystems notched up a series B round that hiked its overall funding to $125m.

The investment and collaboration unit combines portfolio companies and corporate venturing staff from Eon and peer Innogy, which it acquired earlier this year.

Ping An's lending and wealth management spinoff, valued above $39bn two years ago, has selected the New York Stock Exchange for its flotation.

The Novo-backed CAH therapy developer has set the range for an offering set to net it between $60m and $80m in proceeds.

Existing investors including Intel Capital contributed to the $93.9m first close of the micro-LED technology developer's series D round.

UCB Pharma co-led a series A round for the kidney disease-focused drug developer through its UCB Ventures vehicle.

Schlumberger-backed enterprise security software provider Onapsis has now raised more than $113m altogether.

Hyundai Mobis and carmakers General Motors and SAIC Motors will help the company develop its augmented reality head-up displays.

Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.

One97's gaming app, PFG, launched the $1.4m fund alongside more than $40m in support for the domestic gaming and fantasy sports space.